BCM
AVPT icon

Bayesian Capital Management’s AvePoint AVPT Stock Holding History

Bayesian Capital Management’s Portfolio AVPT Stock Details AVPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-20,373
Closed -$240K – 691
2024
Q3 		$240K Buy
20,373
+5,600
+38% +$61.3K 0.03% 529
2024
Q2 		$154K Sell
14,773
-1,644
-10% -$14.3K 0.02% 631
2024
Q1 		$130K Buy
+16,417
New +$129K 0.01% 699
2022
Q2 		– Sell
-11,178
Closed -$59K – 780
2022
Q1 		$59K Buy
+11,178
New +$64K 0.01% 722

Other funds holding AVPT

A6
Anchor @ 65 Singapore $355M AUM 27.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
PCM
Parsifal Capital Management Greenwich, Connecticut $826M AUM 47.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bayesian Capital Management's AVPT Position: Q4 2024 in Review

Bayesian Capital Management sold out of AvePoint (AVPT) in Q4 2024, closing a stake of 20,373 shares — an estimated $240K sold.

Bayesian Capital Management first reported a position in AVPT in Q1 2022 and held it in 4 quarters. The position peaked at $240K in Q3 2024. 238 funds tracked by Wall St. Rank hold AVPT as of Q4 2024.

  • Bayesian Capital Management reported no remaining AvePoint position as of Q4 2024 after selling out during the quarter.
  • Bayesian Capital Management sold 20,373 AvePoint shares in Q4 2024, an estimated $240K.
  • Bayesian Capital Management first reported a position in AvePoint in Q1 2022 and held it in 4 quarters.
  • Bayesian Capital Management's AvePoint position peaked at $240K in Q3 2024.
  • 238 funds tracked by Wall St. Rank held AvePoint as of Q4 2024.

Based on Bayesian Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.